In an animal experiment, the Y1 receptor was shown to play an important role in AD-related cognitive impairment, as memory impairment in rats was improved by the NPY and Y1 receptor agonist, while the Y1 receptor antagonist had the opposite effect [31]. Here, NPY is linked to Alzheimer disease.